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Objective: To evaluate the efficacy of ultrasound guided dry needling and autologous blood injection for the
treatment of patellar tendinosis.
Design: Prospective cohort study.
Setting: Hospital/clinic based.
Patients: 47 knees in 44 patients (40 men, 7 women, mean age 34.5 years, age range 17 to 54 years) with
refractory tendinosis underwent sonographic examination of the patellar tendon following referral with a
clinical diagnosis of patellar tendinosis (mean symptom duration 12.9 months).
Interventions: Ultrasound guided dry needling and injection of autologous blood into the site of patellar
tendinosis was performed on two occasions four weeks apart.
Main outcome measures: Pre- and post-procedure Victorian Institute of Sport Assessment scores (VISA) were
collected to assess patient response to treatment. Follow up ultrasound examination was done in 21 patients
(22 knees).
Results: Therapeutic intervention led to a significant improvement in VISA score: mean pre-procedure
score = 39.8 (range 8 to 72) v mean post procedure score = 74.3 (range 29 to 100), p,0.001; mean follow
up 14.8 months (range 6 to 22 months). Patients were able to return to their sporting interests. Follow up
sonographic assessment showed a reduction in overall tendon thickness and in the size of the area of
tendinosis (hypoechoic/anechoic areas within the proximal patellar tendon). A reduction was identified in
interstitial tears within the tendon substance. Neovascularity did not reduce significantly or even increased.
Conclusions: Dry needling and autologous blood injection under ultrasound guidance shows promise as a
treatment for patients with patellar tendinosis.
P
atellar tendinosis or jumper’s knee refers to a clinical
syndrome characterised by anterior knee pain and tender-
ness at the inferior pole of the patella. It is recognised that
this represents a phenomenon of myxoid degeneration and
tearing of collagen fibres rather than being secondary to
inflammation.1–3 This condition often causes morbidity in sport
and may be refractory to treatment. Various techniques have
been adopted for the treatment of patellar tendinosis, including
physiotherapy,4 sclerosant injection,5 steroid injection,6 extra-
corporeal shock wave therapy,7 and surgical decompression
with resection of the affected tendon and open stimulation
techniques.7–9
Autologous blood injection has been evaluated as a treatment
for lateral epicondylitis in humans,10 11 and in vitro studies have
been carried out in rabbit patellar tendons.12
Our aim in the current study was to assess the efficacy of
ultrasound guided dry needling and injection of autologous
blood into the patellar tendon as a treatment for proximal
patellar tendinosis. Following treatment, the patient adopts a
standardised physiotherapy protocol to aid rehabilitation before
re-starting full sporting activity.
METHODS
Patients
Forty seven knees in 44 consecutive patients were included in
the study, which involved sonographic assessment of the
patellar tendon and autologous blood injection. Informed
consent of the patients and institutional review board approval
were obtained before recruitment. There were 40 men and
seven women (mean age 34.5 years, range 17 to 54 years) with
22 left and 25 right knees treated. The mean duration of
symptoms was 12.9 months (range 1 to 48 months). Forty
patients described sport as a precipitating factor. These included
football (17), running (11), tennis (4), rugby (3), boxing (1),
triathlon (1), dancing (1), golf (1), and martial arts (1).
Only patients with proximal patellar tendinosis were
included in the study. Three patients were excluded as
ultrasound showed the presence of multiple focal areas of
calcification within the proximal tendon. It was felt that this
might be an adverse factor in tendon healing. Two patients who
had undergone previous surgery for anterior cruciate ligament
reconstruction were also excluded. Pre-procedure Victorian
Institute of Sport Assessment scores (VISA)13 were obtained in
all patients to allow quantification of the symptoms and follow
up assessment of the efficacy of treatment.
Sonographic technique
Sonography of the patellar tendon was carried out with the
patient lying supine on an examination couch. The patient was
positioned with the knee partially flexed by placing a pillow
behind it. During sonography the patellar tendon was therefore
under a degree of tension and the wavy configuration that is
evident with the knee in full extension was abolished. Patients
underwent diagnostic examination and therapeutic interven-
tion at several institutions where the senior author practices.
Ultrasound machines from two manufacturers were used:
Siemens (Acuson) Sequoia (Siemens Medical Solutions,
Abbreviation: VISA, Victorian Institute of Sport assessment score
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Mountain View, California, USA) with a 15L8W transducer and
a Toshiba 5500.
Sonographic image interpretation
The patellar tendon was examined in both the transverse and
longitudinal planes to confirm the imaging findings. The
diagnosis of patellar tendinosis was based on the presence of
four characteristic sonographic features. These included tendon
size, focal alteration in tendon echotexture, interstitial clefts or
tears (fibrillar disruption), and neovascularity (fig 1).
All patients included in the study had a hypoechoic tendon
with loss of the normal fibrillar architecture in the affected
tendon segment. A focal increase in proximal patellar tendon
thickness was also universally apparent. Discreet interstitial
tears were present in 31 patients (66%), with no intrasubstance
tear identified in the remainder. Neovascularity was present in
39 patients (83%) (23 mild, 13 moderate, and three severe).
Procedure
Three millilitres of autologous blood were obtained from the
antecubital fossa. Under aseptic technique and sonographic
guidance, 3 ml of 0.5% bupivicaine was infiltrated along the
superficial and deep aspects of the patellar tendon at the site of
tendinosis. Once the local anaesthetic had been given sufficient
time to act, the needle tip was positioned centrally within the
site of tendinosis (fig 2). Following this the tendon was ‘‘dry
needled’’, passing the needle repeatedly through the abnormal
tendon substance for a one minute period. The local anaesthetic
syringe was then removed from the needle and the autologous
blood filled syringe was attached, followed by slow injection of
the blood. If areas of interstitial tears were evident on
sonography, these were targeted for injection of the blood.
Filling of these clefts can be directly visualised as fluid
permeating between the abnormal hypoechoic clefts.
Follow up and physiotherapy protocol
Following the initial treatment, patients were advised to cease
the sporting activities that precipitated their symptoms but to
continue their activities of daily living. If they had been
undergoing physiotherapy before autologous blood injection
this was postponed until the treatment course was completed.
A second injection was then scheduled at an interval of four
weeks following the initial injection. At this time, a repeat
sonographic assessment was undertaken, followed by dry
needling and autologous blood injection using the same
technique as at the initial visit. After the second injection, the
patients were referred for a standardised physiotherapy
programme specifically designed for the study. At the outset
of treatment all patients are advised that the treatment consists
of both injection and physiotherapy, and they should expect a
three month healing period before they resume their previous
levels of sporting activity.
All patients were asked to complete post-procedure VISA
scores to allow assessment of the efficacy of the treatment.
Twenty one patients (24 knees) were invited back for a repeat
ultrasound examination to assess the changes in the patellar
tendon following treatment.
Statistical analysis
Comparison was made between the pre- and post-procedure
VISA score. Normality of the difference between the pre- and
post-procedural VISA scores was assessed using the
Kolmogorov–Smirnov test. The data did not show evidence of
non-normality and were analysed using the paired sample
t test. All statistical analysis was carried out using SPSS for
Windows, version 14.0 (Chicago, Illinois, USA) and probability
(p) values ,0.05 were considered significant.
RESULTS
Clinical outcome
The mean (SD) pre-procedural VISA score was 39.8 (16.3),
range 8 to 72. It increased significantly to 74.3 (17.5), range 29
to 100, on post-procedure follow up (t = 13.770, df = 43,
p,0.001). The mean follow up period was 14.8 months, range
6 to 22. There were three treatment failures among the initial 47
patients. These patients failed to achieve symptomatic improve-
ment. At follow up all three had undergone surgical decom-
pression and so a follow up VISA score could not be recorded.
One of these patients had two autologous blood injections but
did not follow the physiotherapy protocol and returned
immediately to sporting activity. The further two cases under-
went routine injection and physiotherapy as per protocol.
Ultrasound outcome
Follow up ultrasound examination was undertaken using the
same technique, knee position, and machine as in the pre-
treatment examination. The ultrasound features that were used
to diagnose patellar tendinosis were reassessed for interval
change. These included overall tendon thickness, focal altera-
tion in tendon echotexture, interstitial clefts or tears (fibrillar
disruption), and neovascularity.
In all, 21 patients (24 knees) returned for ultrasound follow
up examination. In 22 cases, a reduction in proximal tendon
thickness was observed, with no difference in the remaining
Figure 1 Longitudinal image of the proximal patellar tendon. Colour
Doppler shows marked neovascularity in the hypoechoic segment of the
proximal patellar tendon.
Figure 2 Longitudinal image of the proximal patellar tendon. The needle
(arrow) has been inserted into the hypoechoic area before dry needling
and autologous blood injection.
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two cases. Furthermore, the size of the focal alteration in
tendon echotexture reduced in 22 cases (fig 3), with one case
remaining unchanged and one case showing an increase in
length of the abnormally hypoechoic segment. In only a single
case, however, was the tendon appearance classed as com-
pletely normal—that is, a return to the normal fibrillar pattern
of the proximal patellar tendon. Two patients had tiny foci of
calcification at the previous site of tendinosis (2 mm). Residual
interstitial fissures/tears were identified in three cases but had
resolved in 14. Neovascularity remained in 23 cases. The degree
of neovascularity remained unchanged in nine cases, had
lessened in five, and was more florid in nine.
DISCUSSION
Patellar tendinosis or jumper’s knee is an extremely common
knee disorder with an estimated incidence of between 13% and
20% in athletic populations.14–16 Various possible intrinsic
aetiologies for this condition have been proposed in athletes,
including abnormal patellar tracking,17 limb length discre-
pancy,14 and reduced flexibility of the quadriceps and ham-
string muscle groups.18 While patellar tendinosis is often
diagnosed clinically, magnetic resonance imaging and ultra-
sound are now well established.6 19–22 The sonographic features
of tendinosis are well described in both the patellar tendon and
elsewhere.10 20 23 24 We used four sonographic features for
diagnosis and ultrasound follow up. These included tendon
size, focal alteration in tendon echotexture, interstitial clefts or
tears (fibrillar disruption), and neovascularity. The degree of
neovascularity identified in patients with patellar tendinosis is
affected by the position of the knee during sonographic
assessment. In the extended position, neovascularity appears
more florid and when tension is applied on the tendon in
flexion, some of the neovascularity is abolished. For the
purposes of the study and to ensure continuity, the knee was
examined in a consistent position, resting on a pillow. This
enabled an assessment to be made on follow up sonography of
the degree of neovascularity. When the patient returned at four
weeks for the second injection, we often observed that the
hypoechoic focus in the proximal patellar tendon had become
more echogenic. We postulate that this accumulation of
echogenic material relates to the formation of immature scar
tissue/granulation tissue, though we have no pathological
evidence of this. Furthermore, there were changes in the
neovascularity following the autologous blood injection. We
anticipated that a decrease in tendon neovascularity would be
observed; however, this only occurred in nine patients. An
equal number of patients showed an increase in vascularity,
which we cannot explain. This occurred despite resolution in
symptoms and a return to sporting activity.
We assessed the clinical outcome of patients using VISA. This
assesses symptomatology, simple function, and the ability to
undertake sporting activity, scored out of 100. It has been
validated as a clinical method for assessing the severity of a
patient’s symptoms in patellar tendinosis and has been shown
to be a reliable and reproducible index.13 We were able to
demonstrated a significant in improvement in symptoms using
our technique.
The injection of autologous blood into tendons has been
evaluated in studies assessing the in vitro12 and in vivo10 11 effects
on tendons. Taylor and co-workers assessed the effects of
autologous blood injection on the strength of rabbit patellar
tendons and found a significant increase in injected tendon
strength when compared with the contralateral normal side.12
Connell and co-workers reported clinical and sonographic
improvement in patients treated with autologous blood injections
for lateral epicondylitis.10 In our study, the patellar tendon
underwent barbotage or ‘‘dry needling’’ before autologous blood
injection in all cases included in the study. This technique
involves the repeated lancing of the area of abnormal tendon. It is
done to stimulate an inflammatory response within the tendon.
There is focal disruption of the collagen fibres within the area of
tendinosis, so the process of dry needling is done to incite internal
haemorrhage. It is then hypothesised that the inflammatory
response induces the formation of granulation tissue which
strengthens the tendon.11 Although our study design does not
allow comment on the mechanism of action of this technique,
several workers have postulated possible biological mechanisms
that may contribute. Anitua and co-workers investigated the
effects of platelet-rich clots on human tendon cells in culture.
They found that autologous preparations rich in growth factors
induce cell proliferation and promote synthesis of angiogenic
factors during the healing process.25 Furthermore, it has been
hypothesized that basic fibroblast growth factor and transform-
ing growth factor b may act as humoral mediators in the
induction of the healing cascade.26
We believe that it is essential that this procedure should be
done under ultrasound guidance. Fredberg and co-workers
found that the clinical suspicion of tendonitis could be
confirmed by ultrasound evaluation in only one third of cases.6
Ultrasound therefore allows confirmation of the diagnosis and
provides an imaging baseline under which the response can be
assessed. It allows the area of tendon abnormality to be located
precisely and interstitial tears to be identified and targeted for
blood injection. Frequently, the abnormality can be quite focal
and the injectate can be seen permeating the clefts within
the tendon substance. In addition, physiotherapy plays a vital
role in the ongoing treatment of patients following a period of
rest and the series of injections. We used a standardised
protocol based on the findings of Purdam et al.27 Loading of the
patellar tendon was achieved by decline eccentric dips, with
Figure 3 Longitudinal image of the proximal patellar tendon pre-
treatment and 6 months post-treatment in the same patient. The post-
treatment image shows near complete resolution of the hypoechoic
segment in the proximal patellar tendon. There has been return of the
normal echogenic fibrillar pattern in the tendon. There is a tiny residual
hypoechoic segment at the insertion.
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incrementally increasing load over three to six months, until
the subject had returned to sport. All subjects also received
quadriceps, hamstring, and calf stretches. The programme was
home based, with regular physiotherapy clinic visits to guide
the subject’s progression.
There are various limitations to our study. We are, in essence,
evaluating two therapies simultaneously. Autologous blood
injection and dry needling is combined with physiotherapy as
part of our treatment protocol. We therefore do not know the
relative importance of the autologous blood injection and the
dry needling in the therapeutic outcome of the group studied.
Previous workers have identified good results with painful
eccentric quadriceps training, with significant improvement in
clinical outcome.4 However, most of our patients had under-
gone a course of physiotherapy, and the tendinosis had proved
refractory to this initial treatment. Second, although the VISA
score provides an objective measure of clinical outcome in
patients treated with this technique, we do not have any other
objective measurement of tendon healing. The ultrasound
findings are descriptive and rather subjective. It would be
difficult to justify biopsy of the tendon to provide histological
evidence of tendon healing. With this in mind, ultrasound was
chosen as the method to monitor the ‘‘healing response’’ and to
observe the sonographic appearances of tendons treated by this
new technique. Further research is required with a randomised
controlled trial of autologous blood injection/physiotherapy
versus physiotherapy alone.
CONCLUSIONS
Dry needling and injection of autologous blood for patellar
tendinosis shows promise as an alternative treatment for this
chronic condition. It is important to carry out this technique
under sonographic guidance so that the abnormal tendon can
be targeted precisely for dry needling and injection of blood.
The patient subsequently undergoes a course of physiotherapy
following initial treatment before resuming sporting activity.
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What this study adds
N This study reports the technique of dry needling and
autologous blood injection under sonographic guidance
as a therapeutic option for patellar tendinosis.
N Therapeutic intervention led to a significant improvement
in VISA score as a measure of clinical outcome.
What is already known on this topic
N Patellar tendinosis is a common problem causing
morbidity in sport. It is often refractory to treatment.
Autologous blood injection has been reported as
showing promise in the treatment of this condition at
other sites, for example in medial and lateral epicondy-
litis.
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